Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 76 AL 90

Metal-based nanoparticles' potential in Alzheimer's disease diagnosis, therapy and theranostics

Khorrami S, Alifarsangi A, Mohammed LJ, Amshawee AM, Zarrabi A.

Nanoscale. 2026 Sep 17;18(35):18670-18694. doi: 10.1039/d5nr04613k.

Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis

Han P, Dong P, Zhou Y, Zhang L, Mahomed O.

J Vis Exp. 2026 Sep 1;(235). doi: 10.3791/72385.

Expert opinion on Alzheimer's disease diagnostics and management in Central Eastern European countries representing 88 million population

Mimica N, Dumitrescu L, Gregorič Kramberger M, Hort J, Kovács T, Popadić K, Popescu BO, Rakuša M, Rejdak K, Turčáni P.

Neurol Sci. 2026 Sep 9;47(10):768. doi: 10.1007/s10072-026-09386-6.

[Antibody therapy in Alzheimer's disease]

Schnieder M.

Z Gerontol Geriatr. 2026 Oct;59(6):522-530. doi: 10.1007/s00391-026-02640-8. Epub 2026 Sep 9.

Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease

Greenberg SM, Iadecola C, Chou SH, Cogswell PM, Elkind MSV, Hicks WJ, Le C, Levine DA, Lipton R, Massimo L, Mohl SM, Seshadri S, Snyder HM, Yaffe K, Zachrison KS; ARIA Summit Working Group.

J Am Heart Assoc. 2026 Sep;15(17):e048108. doi: 10.1161/JAHA.125.048108. Epub 2026 Aug 20.

Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations

Sarangal M, Sarangal C, Vora J, Soni K.

Psychopharmacol Bull. 2026 Sep 18;56(4 Suppl 1):82-87. doi: 10.64719/pb.20773.

Bacopa monnieri and Alzheimer's disease: mechanistic convergence, cognitive outcomes and translational perspectives

Kumawat A, Sharma MM, Nathani S.

Inflammopharmacology. 2026 Sep;34(9):6035-6057. doi: 10.1007/s10787-026-02369-1. Epub 2026 Aug 19.

Efficacy of Brexpiprazole on Neuropsychiatric Symptoms and Impact on Caregivers: Pooled Neuropsychiatric Inventory (NPI) Analysis in Patients With Agitation Associated With Dementia due to Alzheimer's Disease

Grossberg GT, Sabbagh MN, Chumki SR, Wang D, Such P, Zhang Z, Palma AM, Cummings JL.

J Geriatr Psychiatry Neurol. 2026 Sep;39(5):589-601. doi: 10.1177/08919887251407124. Epub 2025 Dec 24.

The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review

Moore GJ, Bose N, Henter ID, Manji HK.

JAMA Psychiatry. 2026 Sep 1;83(9):976-986. doi: 10.1001/jamapsychiatry.2026.1296.

Cannabinoids Treatment for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis With Bayesian and Sequential Trial Analyses

da Silva AMP, de Siqueira Lima DV Jr, Figueiroa Souza R, Lopes VHP, Januario Campos Cardoso L, Ornelas Pinto EL, Gonçalves OR, Braga C, Cal H, Haddad DS, Vasconcelos SMM, Duarte FS, Perry G, Anghinah R.

Am J Geriatr Psychiatry. 2026 Sep;34(9):1167-1183. doi: 10.1016/j.jagp.2026.05.016. Epub 2026 May 29.

Targeted Treatment of Agitation in Alzheimer's Dementia: Prioritizing Function and Safety Over Sedation and Other Serious Harms

Tariot PN, Citrome L, Clevenger CK, Jackson WC, Montano CB, Patel A, Porsteinsson AP, Sabbagh M.

Prim Care Companion CNS Disord. 2026 Sep 22;28(5):haadachi2603. doi: 10.4088/PCC.haadachi2603.

A scoping review of frontal cortex tDCS on neuropsychological functioning in older adults with mild cognitive impairment and Alzheimer's Clinical Syndrome

Helphrey JH, Hart J, McClintock SM, Peters ME, Thakkar VJ, LoBue C.

Int Rev Psychiatry. 2026 Sep;38(6):720-736. doi: 10.1080/09540261.2026.2647921. Epub 2026 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias